Their findings show that EV TDP-43 levels and 3R/4R tau isoform ratios effectively discriminate between diagnostic groups and strongly correlate with disease severity, highlighting their potential as biomarkers for FTD disease monitoring [12]. This evidence concerns the gene MAPT and frontotemporal dementia.